JPS56139442A - Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof - Google Patents

Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof

Info

Publication number
JPS56139442A
JPS56139442A JP3305481A JP3305481A JPS56139442A JP S56139442 A JPS56139442 A JP S56139442A JP 3305481 A JP3305481 A JP 3305481A JP 3305481 A JP3305481 A JP 3305481A JP S56139442 A JPS56139442 A JP S56139442A
Authority
JP
Japan
Prior art keywords
carnitine
medicine
manufacture
effective ingredient
acyl derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3305481A
Other languages
English (en)
Inventor
Kabatsutsua Kuraujio
De Bitsuto Paoro
Orunera Chinchi Maria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JPS56139442A publication Critical patent/JPS56139442A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP3305481A 1980-03-06 1981-03-06 Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof Pending JPS56139442A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48099/80A IT1145362B (it) 1980-03-06 1980-03-06 Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico

Publications (1)

Publication Number Publication Date
JPS56139442A true JPS56139442A (en) 1981-10-30

Family

ID=11264505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3305481A Pending JPS56139442A (en) 1980-03-06 1981-03-06 Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof

Country Status (22)

Country Link
US (2) US4766222A (ja)
JP (1) JPS56139442A (ja)
AR (1) AR228591A1 (ja)
AT (1) AT376200B (ja)
AU (1) AU543799B2 (ja)
BE (1) BE887695A (ja)
CA (1) CA1178971A (ja)
CH (1) CH653008A5 (ja)
DE (1) DE3107743A1 (ja)
DK (1) DK154424C (ja)
ES (1) ES500131A0 (ja)
FI (1) FI78680C (ja)
FR (1) FR2477536B1 (ja)
GB (1) GB2071091B (ja)
GR (1) GR74440B (ja)
IE (1) IE50959B1 (ja)
IL (1) IL62189A (ja)
IT (1) IT1145362B (ja)
LU (1) LU83183A1 (ja)
MX (1) MX155928A (ja)
NL (1) NL8101067A (ja)
SE (1) SE452004B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014105221A (ja) * 2012-11-22 2014-06-09 Yamagata Univ 生体適合性ポリマー及びその製造方法並びにそれを製造するための新規化合物
JP2020522534A (ja) * 2017-06-06 2020-07-30 ウェイン ステート ユニバーシティＷａｙｎｅ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ カルニチン由来材料に関する方法および組成物

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
WO2001032168A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
CA2561733A1 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS462247A (ja) * 1970-03-02 1971-10-12
JPS5481963A (en) * 1977-12-13 1979-06-29 Ihachi Nosaka Roll paper holder for lavatory
JPS5554821A (en) * 1978-10-18 1980-04-22 Iseki Agricult Mach Discharging dust adjuster of thresher

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1108125A (fr) * 1953-05-08 1956-01-09 Laboratoires Labaz Soc D Procédé de préparation d'un dérivé stable de la carnitine
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
US4518776A (en) * 1982-07-19 1985-05-21 Ciba Geigy Corporation Process for producing sulfonylureas
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US4707491A (en) * 1985-12-20 1987-11-17 Washington University Anticonvulsant γ-thiobutyrolactone derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS462247A (ja) * 1970-03-02 1971-10-12
JPS5481963A (en) * 1977-12-13 1979-06-29 Ihachi Nosaka Roll paper holder for lavatory
JPS5554821A (en) * 1978-10-18 1980-04-22 Iseki Agricult Mach Discharging dust adjuster of thresher

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014105221A (ja) * 2012-11-22 2014-06-09 Yamagata Univ 生体適合性ポリマー及びその製造方法並びにそれを製造するための新規化合物
JP2020522534A (ja) * 2017-06-06 2020-07-30 ウェイン ステート ユニバーシティＷａｙｎｅ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ カルニチン由来材料に関する方法および組成物

Also Published As

Publication number Publication date
IL62189A0 (en) 1981-03-31
IT1145362B (it) 1986-11-05
ES8201535A1 (es) 1982-01-01
DK154424C (da) 1989-05-22
AT376200B (de) 1984-10-25
LU83183A1 (fr) 1981-06-24
AU6802881A (en) 1981-09-24
IE50959B1 (en) 1986-08-20
FI810695L (fi) 1981-09-07
GB2071091A (en) 1981-09-16
GB2071091B (en) 1984-09-12
ES500131A0 (es) 1982-01-01
FI78680B (fi) 1989-05-31
AU543799B2 (en) 1985-05-02
US4766222A (en) 1988-08-23
SE452004B (sv) 1987-11-09
SE8101267L (sv) 1981-09-07
IT8048099A0 (it) 1980-03-06
GR74440B (ja) 1984-06-28
CH653008A5 (it) 1985-12-13
FR2477536A1 (fr) 1981-09-11
IL62189A (en) 1985-10-31
IE810359L (en) 1981-09-06
US4859698A (en) 1989-08-22
ATA103981A (de) 1984-03-15
BE887695A (fr) 1981-06-15
CA1178971A (en) 1984-12-04
DK154424B (da) 1988-11-14
FR2477536B1 (fr) 1986-04-04
DE3107743A1 (de) 1981-12-03
FI78680C (fi) 1989-09-11
DK100181A (da) 1981-09-07
AR228591A1 (es) 1983-03-30
NL8101067A (nl) 1981-10-01
MX155928A (es) 1988-05-24

Similar Documents

Publication Publication Date Title
IL64573A (en) Derivatives of formylphenoxyalkanoic acids and formylphenoxymethylbenzoic acids,their preparation and pharmaceutical formulations containing them
JPS57181043A (en) Arylcyclobutylamine derivative as medicine and manufacture
IL57662A (en) Acyl-esters of carnitine,process for their preparation and pharmaceutical compositions comprising them
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
HK49188A (en) Acyl derivatives of 1,4:3,6-dianhydro-hexitoles,method for their preparation and their pharmaceutical use
NZ191709A (en) Naphtylmethyl-piperidines and pharmaceutical compostions intermediates
JPS56139442A (en) Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof
IL64146A0 (en) Derivatives of thieno-pyridinone,the method of their preparation and their therapeutic use
GB2086912B (en) Enkephalin derivatives production thereof and pharmaceutical compositions
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
IL59973A (en) Phenylethylamine derivatives,their preparation and pharmaceutical compositions comprising them
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
DE3169890D1 (en) Derivative of n-acetilcysteine having therapeutical activity, process for its preparation and related pharmaceutical compositions
JPS5721354A (en) Esters of carnitine alkoxy-acyl derivatives, manufacture and medicinal composition as effective component thereof
ZA814532B (en) Aminocyclopentanone amides and their preparation and pharmaceutical formulation
IT8247807A0 (it) 2,1,3-benzotiadiazoli e 2,1,3,-benzossadiazoli, loro preparazione e loro applicazione come medicamenti
GB2045743B (en) Derivatives of 6-methoxy-2-acetylnaphthalene oxime their preparation and their apllication as medicaments
JPS56103169A (en) Phenyll11morpholinoo44butenee11oll3 derivative* its manufacture and therapeutic application
DE3266640D1 (en) Heterocyclic derivatives of amidoximes, their preparation and therapeutic uses
NZ196244A (en) Indane derivatives and pharmaceutical compositions
JPS56154446A (en) Novel derivative of 2-amino-phenethylamine, its manufacture and novel medicine containing it
DE3169889D1 (en) Derivative of alfa-mercaptopropionilglicine having therapeutical activity, process for its preparation and related pharmaceutical compositions
GB2079281B (en) Aminocyclopentanone amides and their preparation and pharmaceutical formulation
DE3069781D1 (en) 2-amino-benzoic-acid derivatives, their preparation and their use as medicines or intermediates
IT8147569A0 (it) 2-amminometil-6-alogeno-fenoli loro preparazione e loro applicazione come medicamenti